FDA Inspection 654554 — AstraZeneca AB
The FDA completed an inspection of AstraZeneca AB on Mar 25, 2010 in Sodertalje. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 25, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sodertalje (Sweden)